5	1:0,0,0,0
qvibb	1:0,0,0,0
published	1:0,0,0,0
every	1:0,0,0,0
little	1:0,0,0,0
while	1:0,0,0,0
whenever	1:0,0,0,0
a	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
good	1:0,0,0,0;2:0,0,0,0
purpose	1:0,0,0,0;2:0,0,0,0;4:0,0,0,0
can	1:0,0,0,0
be	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
served,	1:0,0,0,0
and	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
mailed	1:0,0,0,0
free	1:0,0,0,0;2:0,0,0,0
o	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
f	1:0,0,0,0;1:0,0,0,0
charge	1:0,0,0,0
to	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
any	1:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
member	1:0,0,0,0
the	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
medical	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
profession	1:0,0,0,0
who	1:0,0,0,0
will	1:0,0,0,0
send	1:0,0,0,0
us	1:0,0,0,0
his	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
name	1:0,0,0,0
address	1:0,0,0,0
fo	1:0,0,0,0
r	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
our	1:0,0,0,0
mailing	1:0,0,0,0
lisu	1:0,0,0,0
£	1:0,0,0,0
.	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
s	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
q	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
u	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
ib	1:0,0,0,0
b	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
so	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
n	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
s,	1:0,0,0,0
e	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
w	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0
yo	1:0,0,0,0
k	1:0,0,0,0
department	1:0,0,0,0;4:0,0,0,0
october,	1:0,0,0,0
1916	1:0,0,0,0
leucocyte	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
extract,	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0
squibb	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
an	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
extract	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
of	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
leucocytes,	1:0,0,0,0
made	1:0,0,0,0;2:0,0,0,0;4:0,0,0,0
according	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
method	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0
hiss	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
for	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
treatment	1:0,0,0,0;4:0,0,0,0
infections,	1:0,0,0,0;2:0,0,0,0
as,	1:0,0,0,0
e.g.,	1:0,0,0,0
pyemia,	1:0,0,0,0;2:0,0,0,0
septicemia,	1:0,0,0,0;2:0,0,0,0
sapremia,	1:0,0,0,0
etc.	1:0,0,0,0;4:0,0,0,0
it	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
may	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
used	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
alone	1:0,0,0,0
or	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
in	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
conjunction	1:0,0,0,0;2:0,0,0,0
with	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
vaccines.	1:0,0,0,0
solution	1:0,0,0,0;1:0,0,0,0;1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
hypophysis,	1:0,0,0,0;3:0,0,0,0;3:0,0,0,0
sterile	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
aqueous	1:0,0,0,0;3:0,0,0,0
principles	1:0,0,0,0;3:0,0,0,0
posterior	1:0,0,0,0;3:0,0,0,0
lobe	1:0,0,0,0;3:0,0,0,0
pituitary	1:0,0,0,0;3:0,0,0,0
body,	1:0,0,0,0;5:0,0,0,0
use	1:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
when	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
vaso	1:0,0,0,0
constrictor	1:0,0,0,0
stimulant	1:0,0,0,0;3:0,0,0,0
unstriped	1:0,0,0,0
muscle	1:0,0,0,0
is	1:0,0,0,0;1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
indicated.	1:0,0,0,0
thromboplastin,	1:0,0,0,0;4:0,0,0,0;5:0,0,0,0
thromboplastic	1:0,0,0,0
substances	1:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
normally	1:0,0,0,0
brain	1:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
ox.	1:0,0,0,0
hemostatic,	1:0,0,0,0
acting,	1:0,0,0,0
not	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
mechanically	1:0,0,0,0
but	1:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
physiologically,	1:0,0,0,0
i.e.,	1:0,0,0,0
by	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
supplying	1:0,0,0,0
normal	1:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
coagulability	1:0,0,0,0;5:0,0,0,0
blood.	1:0,0,0,0;4:0,0,0,0
i	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
l	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
c	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0
y	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
t	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
x	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
6zy^%,	2:0,0,0,0
were	2:0,0,0,0;2:0,0,0,0
improved.	2:0,0,0,0
series	2:0,0,0,0;2:0,0,0,0
cases	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
lobar	2:0,0,0,0
pneu	2:0,0,0,0
monia	2:0,0,0,0
showed	2:0,0,0,0
distinct	2:0,0,0,0;2:0,0,0,0
improvement.	2:0,0,0,0
equally	2:0,0,0,0;2:0,0,0,0
results	2:0,0,0,0;2:0,0,0,0
obtained	2:0,0,0,0
erysipelas.	2:0,0,0,0
d	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
wyer	2:0,0,0,0;2:0,0,0,0
product,	2:0,0,0,0
value	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0
report	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
on	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;5:0,0,0,0
148	2:0,0,0,0
cases.®	2:0,0,0,0
,	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
lexander	2:0,0,0,0
auss	2:0,0,0,0
which	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
was	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0
at	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
first	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
postulated	2:0,0,0,0
theoretically,	2:0,0,0,0
later	2:0,0,0,0
record	2:0,0,0,0
their	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
16	2:0,0,0,0
cases,	2:0,0,0,0
cornprising	2:0,0,0,0
®	2:0,0,0,0;2:0,0,0,0
illiams	2:0,0,0,0
verified	2:0,0,0,0
biological	2:0,0,0,0;2:0,0,0,0
investigations,	2:0,0,0,0
finally	2:0,0,0,0
demon	2:0,0,0,0
variety	2:0,0,0,0
infections.	2:0,0,0,0
j.	2:0,0,0,0;4:0,0,0,0
g.	2:0,0,0,0;3:0,0,0,0
reviews	2:0,0,0,0
clinical	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
strated	2:0,0,0,0
established	2:0,0,0,0
experience.	2:0,0,0,0
experience	2:0,0,0,0
important	2:0,0,0,0;2:0,0,0,0
role	2:0,0,0,0
played	2:0,0,0,0
leucocytes	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
combating	2:0,0,0,0
over	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0
400	2:0,0,0,0
cases.	2:0,0,0,0
results,	2:0,0,0,0
as	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
well	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
bacterial	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
infection	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
known;	2:0,0,0,0
idea	2:0,0,0,0;2:0,0,0,0
that	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
tests,	2:0,0,0,0
indicate	2:0,0,0,0
these	2:0,0,0,0;2:0,0,0,0;5:0,0,0,0
cells,	2:0,0,0,0
virtue	2:0,0,0,0
chemical	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
physician	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0
has	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
most	2:0,0,0,0;4:0,0,0,0
therapeutic	2:0,0,0,0
agent.	2:0,0,0,0
enzymes	2:0,0,0,0
they	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
contain,	2:0,0,0,0
could	2:0,0,0,0;4:0,0,0,0
organism	2:0,0,0,0
struggling	2:0,0,0,0
against	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
prepared	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
under	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
strictest	2:0,0,0,0
aseptic	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
precautions,	2:0,0,0,0
invasion,	2:0,0,0,0
seemed	2:0,0,0,0
grounded.	2:0,0,0,0
this	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
hiss.	2:0,0,0,0
secured	2:0,0,0,0
inciting	2:0,0,0,0
purulent	2:0,0,0,0
exudate	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
mind	2:0,0,0,0
experimental	2:0,0,0,0;2:0,0,0,0
work	2:0,0,0,0;2:0,0,0,0;4:0,0,0,0
undertaken	2:0,0,0,0
pleural	2:0,0,0,0
cavities	2:0,0,0,0
rabbits	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0
other	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
animals	2:0,0,0,0;2:0,0,0,0
studies	2:0,0,0,0
dealt	2:0,0,0,0
part	2:0,0,0,0;4:0,0,0,0
z	2:0,0,0,0
.^	2:0,0,0,0
insser	2:0,0,0,0
through	2:0,0,0,0;5:0,0,0,0
injection	2:0,0,0,0;3:0,0,0,0
vegetable	2:0,0,0,0
protein	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
protection	2:0,0,0,0
means	2:0,0,0,0
solution.	2:0,0,0,0
after	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
collected	2:0,0,0,0
sufficient	2:0,0,0,0
fatal	2:0,0,0,0;2:0,0,0,0
doses	2:0,0,0,0;2:0,0,0,0
various	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
pathogenic	2:0,0,0,0
bacteria,	2:0,0,0,0
quantity	2:0,0,0,0
aspirated	2:0,0,0,0
strict	2:0,0,0,0
precau	2:0,0,0,0
cluding	2:0,0,0,0
typhoid	2:0,0,0,0;2:0,0,0,0
bacillus,	2:0,0,0,0
streptococcus	2:0,0,0,0
pyogenes,	2:0,0,0,0
tions.	2:0,0,0,0
then	2:0,0,0,0;3:0,0,0,0
centrifuged,	2:0,0,0,0
staphylococcus,	2:0,0,0,0
pneumococcus,	2:0,0,0,0
meningococcus,	2:0,0,0,0
sediment	2:0,0,0,0
determining	2:0,0,0,0
gonococcus.	2:0,0,0,0
follows:	2:0,0,0,0
from	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
bacteria.	2:0,0,0,0
“	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
extracts	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
have	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
modifying	2:0,0,0,0
curative	2:0,0,0,0
action,	2:0,0,0,0
given	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
elxtract	2:0,0,0,0
indicated	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
acute	2:0,0,0,0
constitutional	2:0,0,0,0
such	2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
subcutaneously	2:0,0,0,0;3:0,0,0,0
intraperitoneally	2:0,0,0,0
rabbits,	2:0,0,0,0
sapremia.	2:0,0,0,0
should	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
replace	2:0,0,0,0
specific	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;4:0,0,0,0
infections	2:0,0,0,0
are	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
rapidly	2:0,0,0,0
treated.	2:0,0,0,0
serums	2:0,0,0,0
antitoxins,	2:0,0,0,0
vaccines;	2:0,0,0,0
very	2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
valuable	2:0,0,0,0;3:0,0,0,0
wh6n	2:0,0,0,0
rabbit	2:0,0,0,0
also	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
active	2:0,0,0,0
pro	2:0,0,0,0;3:0,0,0,0;5:0,0,0,0
them.	2:0,0,0,0
especially	2:0,0,0,0;2:0,0,0,0
impossible	2:0,0,0,0
tecting	2:0,0,0,0
guinea-pigs	2:0,0,0,0;2:0,0,0,0
lethal	2:0,0,0,0
cultures.	2:0,0,0,0
^	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
obtain	2:0,0,0,0
diagnosis	2:0,0,0,0
immunized	2:0,0,0,0
anipials	2:0,0,0,0
patient	2:0,0,0,0
suflfering.	2:0,0,0,0
more	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
seem,	2:0,0,0,0
some	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
instances	2:0,0,0,0
least,	2:0,0,0,0
possess	2:0,0,0,0
even	2:0,0,0,0;3:0,0,0,0
greater	2:0,0,0,0
powers	2:0,0,0,0
than	2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0
animals.”	2:0,0,0,0
desirable	2:0,0,0,0;3:0,0,0,0
stock	2:0,0,0,0
vaccine.	2:0,0,0,0
advantage	2:0,0,0,0
mixed	2:0,0,0,0
vaccines,	2:0,0,0,0
investigators	2:0,0,0,0
further	2:0,0,0,0;3:0,0,0,0;3:0,0,0,0
noted	2:0,0,0,0
merely	2:0,0,0,0
supply	2:0,0,0,0
mixture	2:0,0,0,0
hope	2:0,0,0,0
cause	2:0,0,0,0;3:0,0,0,0
precipitation	2:0,0,0,0
cholera	2:0,0,0,0;2:0,0,0,0
one	2:0,0,0,0;2:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
another	2:0,0,0,0;4:0,0,0,0
ingredients	2:0,0,0,0
prove	2:0,0,0,0
benefit.	2:0,0,0,0
spirilla,	2:0,0,0,0
streptococci,	2:0,0,0,0
bacilli,	2:0,0,0,0
diphtheria	2:0,0,0,0
bacilli;	2:0,0,0,0
exert	2:0,0,0,0
marked	2:0,0,0,0
sold	2:0,0,0,0;3:0,0,0,0
syringes	2:0,0,0,0
con	2:0,0,0,0
protective	2:0,0,0,0
influence	2:0,0,0,0
experimentally	2:0,0,0,0
taining	2:0,0,0,0
10	2:0,0,0,0
mils	2:0,0,0,0;5:0,0,0,0
(10	2:0,0,0,0
cc.),	2:0,0,0,0
average	2:0,0,0,0;3:0,0,0,0
dose	2:0,0,0,0;5:0,0,0,0
infected	2:0,0,0,0
vibrio	2:0,0,0,0
cholera,	2:0,0,0,0
asiatica,	2:0,0,0,0
three	2:0,0,0,0
times	2:0,0,0,0;5:0,0,0,0
daily	2:0,0,0,0
less	2:0,0,0,0;3:0,0,0,0
often,	2:0,0,0,0
pneumonia.	2:0,0,0,0
response.	2:0,0,0,0
skin	2:0,0,0,0;3:0,0,0,0
thoroughly	2:0,0,0,0
favorable	2:0,0,0,0
evidence	2:0,0,0,0
accumulating.	2:0,0,0,0
sterilized	2:0,0,0,0;3:0,0,0,0
point	2:0,0,0,0;3:0,0,0,0
injection,	2:0,0,0,0
zinsser	2:0,0,0,0
followed	2:0,0,0,0
injected	2:0,0,0,0
subcutaneously.	2:0,0,0,0
favorite	2:0,0,0,0
site	2:0,0,0,0
ab	2:0,0,0,0
staphylococcus	2:0,0,0,0
dominal	2:0,0,0,0
wall,	2:0,0,0,0
loose	2:0,0,0,0
tissues	2:0,0,0,0
back.	2:0,0,0,0
fections.^	2:0,0,0,0
24	2:0,0,0,0
epidemic	2:0,0,0,0
meningitis,	2:0,0,0,0
15,	2:0,0,0,0
*	2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;2:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
record,	2:0,0,0,0;2:0,0,0,0
sept.	2:0,0,0,0;4:0,0,0,0
13.	2:0,0,0,0
9	2:0,0,0,0;2:0,0,0,0
3	2:0,0,0,0
liverpool	2:0,0,0,0
medical-chirurgical	2:0,0,0,0
journal,	2:0,0,0,0
j	2:0,0,0,0;4:0,0,0,0
.,	2:0,0,0,0
1911.	2:0,0,0,0
'^journal	2:0,0,0,0
research,	2:0,0,0,0;2:0,0,0,0
1908,	2:0,0,0,0
ix	2:0,0,0,0
o.	2:0,0,0,0;3:0,0,0,0
3.	2:0,0,0,0
journal	2:0,0,0,0;4:0,0,0,0;4:0,0,0,0
245.	2:0,0,0,0
m	2:0,0,0,0;4:0,0,0,0;5:0,0,0,0
ay	2:0,0,0,0
30.	2:0,0,0,0
«	2:0,0,0,0
4	2:0,0,0,0
h	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
p	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
though	3:0,0,0,0
feeble.	3:0,0,0,0
possible	3:0,0,0,0
initiate	3:0,0,0,0
labor	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
case	3:0,0,0,0;3:0,0,0,0
delivery	3:0,0,0,0
term	3:0,0,0,0
(s	3:0,0,0,0
)	3:0,0,0,0;3:0,0,0,0
olution	3:0,0,0,0
ituitary	3:0,0,0,0
ody	3:0,0,0,0
recommended	3:0,0,0,0
hypophysis	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0
cautiously	3:0,0,0,0;3:0,0,0,0
before	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
complete	3:0,0,0,0;4:0,0,0,0
dilatation	3:0,0,0,0
water-soluble	3:0,0,0,0
pos	3:0,0,0,0
os	3:0,0,0,0
uteri	3:0,0,0,0
taken	3:0,0,0,0;5:0,0,0,0
place,	3:0,0,0,0
otherwise,	3:0,0,0,0
vigorous	3:0,0,0,0
terior	3:0,0,0,0
(pituitary	3:0,0,0,0
body).	3:0,0,0,0
contractions	3:0,0,0,0
rupture	3:0,0,0,0;3:0,0,0,0
uterus.	3:0,0,0,0
lobes	3:0,0,0,0
fresh	3:0,0,0,0
glands	3:0,0,0,0
(of	3:0,0,0,0
cattle)	3:0,0,0,0
there	3:0,0,0,0;3:0,0,0,0
high	3:0,0,0,0
tem	3:0,0,0,0
separated,	3:0,0,0,0
finely	3:0,0,0,0
ground	3:0,0,0,0
conditions,	3:0,0,0,0
perature	3:0,0,0,0
threatened	3:0,0,0,0
eclampsia,	3:0,0,0,0
extracted	3:0,0,0,0
acidulated	3:0,0,0,0
water.	3:0,0,0,0;5:0,0,0,0
resulting	3:0,0,0,0
danger	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
intra-uterine	3:0,0,0,0
asphyxiation	3:0,0,0,0;3:0,0,0,0
child.	3:0,0,0,0;3:0,0,0,0
boiled	3:0,0,0,0
coagulate	3:0,0,0,0
proteins,	3:0,0,0,0
considered	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
slowly	3:0,0,0,0
filtered	3:0,0,0,0
aseptically.	3:0,0,0,0
working	3:0,0,0,0
conditions	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
gressing	3:0,0,0,0
labor,	3:0,0,0,0;3:0,0,0,0
demand	3:0,0,0,0
termination	3:0,0,0,0;3:0,0,0,0
prevents	3:0,0,0,0
contamination	3:0,0,0,0
product	3:0,0,0,0;3:0,0,0,0
toxic	3:0,0,0,0
imperative,	3:0,0,0,0
protracted	3:0,0,0,0
disintegration-products,	3:0,0,0,0
might	3:0,0,0,0
formed	3:0,0,0,0;4:0,0,0,0
volving	3:0,0,0,0
psychic	3:0,0,0,0
shock,	3:0,0,0,0
exhaustion,	3:0,0,0,0
increased	3:0,0,0,0
action	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
during	3:0,0,0,0;3:0,0,0,0
process	3:0,0,0,0
manufacture.	3:0,0,0,0
mother,	3:0,0,0,0
possibility	3:0,0,0,0
heating	3:0,0,0,0
removes	3:0,0,0,0
all	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
inert	3:0,0,0,0
coagulable	3:0,0,0,0
material.	3:0,0,0,0
general	3:0,0,0,0
anesthesia	3:0,0,0,0
does	3:0,0,0,0
next	3:0,0,0,0
standardized,	3:0,0,0,0
interfere	3:0,0,0,0
its	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
action.	3:0,0,0,0
finally,	3:0,0,0,0
held	3:0,0,0,0
dr.	3:0,0,0,0
b.	3:0,0,0,0
adjusted	3:0,0,0,0
,«	3:0,0,0,0
preventative	3:0,0,0,0
post-partum	3:0,0,0,0
hemor	3:0,0,0,0
oth	3:0,0,0,0
1:20,000	3:0,0,0,0
equivalent	3:0,0,0,0
rhage,	3:0,0,0,0
where	3:0,0,0,0;3:0,0,0,0
been	3:0,0,0,0;3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
found	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
certain	3:0,0,0,0;5:0,0,0,0
1:20,ooo,ooo	3:0,0,0,0
histamine	3:0,0,0,0
(beta-iminazolyl-	3:0,0,0,0
ergot.	3:0,0,0,0
ethylamine	3:0,0,0,0
hydrochloride).	3:0,0,0,0
put	3:0,0,0,0
into	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
am	3:0,0,0,0
proved	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
useful	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
slightly	3:0,0,0,0
puls,	3:0,0,0,0
heating.	3:0,0,0,0
being	3:0,0,0,0;5:0,0,0,0
marketed	3:0,0,0,0
contracted	3:0,0,0,0
pelvis,	3:0,0,0,0
placenta	3:0,0,0,0
praevia	3:0,0,0,0
lateralis	3:0,0,0,0
each	3:0,0,0,0
lot	3:0,0,0,0
retested	3:0,0,0,0
physiological	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0
activity.	3:0,0,0,0;3:0,0,0,0
membranes,	3:0,0,0,0
breech	3:0,0,0,0
presentations.	3:0,0,0,0
boxes	3:0,0,0,0
said	3:0,0,0,0
contraindicated,	3:0,0,0,0
six	3:0,0,0,0
ampuls	3:0,0,0,0
each.	3:0,0,0,0
protected	3:0,0,0,0
or*at	3:0,0,0,0
least	3:0,0,0,0
caution	3:0,0,0,0
required	3:0,0,0,0;4:0,0,0,0
use,	3:0,0,0,0
neph	3:0,0,0,0
light,	3:0,0,0,0
oxidation,	3:0,0,0,0
ritis,	3:0,0,0,0
myocarditis,	3:0,0,0,0
arteriosclerosis	3:0,0,0,0
present;	3:0,0,0,0
contamination.	3:0,0,0,0
rigid	3:0,0,0,0
control	3:0,0,0,0
assures	3:0,0,0,0
he	3:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
stage	3:0,0,0,0
uniform	3:0,0,0,0;5:0,0,0,0
definite	3:0,0,0,0
convenient	3:0,0,0,0
already	3:0,0,0,0;3:0,0,0,0
above;	3:0,0,0,0
form	3:0,0,0,0
accurate	3:0,0,0,0
dose.	3:0,0,0,0;3:0,0,0,0
contents	3:0,0,0,0
positively	3:0,0,0,0
contraindicated	3:0,0,0,0
pelvis	3:0,0,0,0
ampul	3:0,0,0,0
mil	3:0,0,0,0
(i	3:0,0,0,0
cc.	3:0,0,0,0
=	3:0,0,0,0
i6	3:0,0,0,0
min.),	3:0,0,0,0
too	3:0,0,0,0
narrow	3:0,0,0,0
permit	3:0,0,0,0
delivery.	3:0,0,0,0
intramuscularly,	3:0,0,0,0
gynecology	3:0,0,0,0
repeated	3:0,0,0,0
thirty	3:0,0,0,0
sixty	3:0,0,0,0
minutes	3:0,0,0,0
if	3:0,0,0,0;3:0,0,0,0
necessary.	3:0,0,0,0
efficient	3:0,0,0,0
hemostatic.	3:0,0,0,0
employed	3:0,0,0,0;5:0,0,0,0
1	3:0,0,0,0
sterilize	3:0,0,0,0
syringe	3:0,0,0,0
boiling,	3:0,0,0,0
menorrhagia,	3:0,0,0,0
metritis,	3:0,0,0,0
endometritis,	3:0,0,0,0
paint	3:0,0,0,0
removal	3:0,0,0,0
fibroid	3:0,0,0,0
tumors;	3:0,0,0,0
hemorrhage	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
due	3:0,0,0,0
tincture	3:0,0,0,0
iodine.	3:0,0,0,0
myomatous	3:0,0,0,0
growths	3:0,0,0,0
diseases	3:0,0,0,0
uterine	3:0,0,0,0;3:0,0,0,0;5:0,0,0,0
appen	3:0,0,0,0
general.	3:0,0,0,0
dages,	3:0,0,0,0
ovarian	3:0,0,0,0
cysts.	3:0,0,0,0
vaso-constrictor	3:0,0,0,0
powerful	3:0,0,0,0
un	3:0,0,0,0
reported	3:0,0,0,0;4:0,0,0,0
stimulate	3:0,0,0,0
striped	3:0,0,0,0
muscle.	3:0,0,0,0
obstetrics.	3:0,0,0,0
muscles	3:0,0,0,0
intestines	3:0,0,0,0
bladder,	3:0,0,0,0
hence	3:0,0,0,0
inertia	3:0,0,0,0
condi	3:0,0,0,0
would	3:0,0,0,0
appear	3:0,0,0,0
loss	3:0,0,0,0
intestinal	3:0,0,0,0;4:0,0,0,0;5:0,0,0,0
tone	3:0,0,0,0
tions	3:0,0,0,0;3:0,0,0,0
rapid	3:0,0,0,0
abdominal	3:0,0,0,0
operations,	3:0,0,0,0
retention	3:0,0,0,0
becomes	3:0,0,0,0;3:0,0,0,0;4:0,0,0,0;4:0,0,0,0
imperative.	3:0,0,0,0
urine	3:0,0,0,0
puerperium	3:0,0,0,0
opera	3:0,0,0,0;4:0,0,0,0
observation,	3:0,0,0,0
uterus	3:0,0,0,0
sensitive	3:0,0,0,0
involving	3:0,0,0,0
abdomen	3:0,0,0,0
vagina.	3:0,0,0,0
progressed,	3:0,0,0,0
response	3:0,0,0,0
prompt	3:0,0,0,0
pains	3:0,0,0,0
set	3:0,0,0,0
in,	3:0,0,0,0
shock	3:0,0,0,0
low	3:0,0,0,0
blood-	3:0,0,0,0
pressure.	3:0,0,0,0
ulletin	3:0,0,0,0
loo,	3:0,0,0,0
hygienic	3:0,0,0,0
aboratory,	3:0,0,0,0
ashington,	3:0,0,0,0
c.	3:0,0,0,0
lipoid	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
therapy	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
appears	4:0,0,0,0
attributable	4:0,0,0,0
constituent	4:0,0,0,0
known	4:0,0,0,0
kephalin.	4:0,0,0,0
shown	4:0,0,0,0
so-called	4:0,0,0,0
fibrin	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
ferment	4:0,0,0,0;4:0,0,0,0
owell	4:0,0,0,0
theories	4:0,0,0,0;4:0,0,0,0
proposed	4:0,0,0,0
explanation	4:0,0,0,0
natural	4:0,0,0,0
probably	4:0,0,0,0
identical	4:0,0,0,0
diphosphatide,	4:0,0,0,0
kephalin,	4:0,0,0,0
coagulation	4:0,0,0,0;4:0,0,0,0
blood	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
many.	4:0,0,0,0
agreed	4:0,0,0,0
isolated	4:0,0,0,0
thudicum.	4:0,0,0,0
involve,	4:0,0,0,0
eventually,	4:0,0,0,0
transformation	4:0,0,0,0;4:0,0,0,0
lancet,	4:0,0,0,0
d.	4:0,0,0,0
de	4:0,0,0,0
’	4:0,0,0,0;4:0,0,0,0
rthur	4:0,0,0,0
irschfelder	4:0,0,0,0
soluble	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
fibrinogen	4:0,0,0,0
insoluble	4:0,0,0,0;4:0,0,0,0
fibrin.	4:0,0,0,0;4:0,0,0,0
activity	4:0,0,0,0
scribed	4:0,0,0,0
applications	4:0,0,0,0
class	4:0,0,0,0
responsible	4:0,0,0,0
attributed	4:0,0,0,0
hemostatic	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
purposes	4:0,0,0,0
title,	4:0,0,0,0
ferment,	4:0,0,0,0
thrombin.	4:0,0,0,0
number	4:0,0,0,0
factors	4:0,0,0,0;4:0,0,0,0
haemostatic.”	4:0,0,0,0
says;	4:0,0,0,0
necessary	4:0,0,0,0;4:0,0,0,0
reaction	4:0,0,0,0;5:0,0,0,0
take	4:0,0,0,0
place.	4:0,0,0,0
evolution	4:0,0,0,0
firm	4:0,0,0,0
clot	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
fluid	4:0,0,0,0
state	4:0,0,0,0
manifest	4:0,0,0,0
two	4:0,0,0,0
minutes,	4:0,0,0,0
circulating	4:0,0,0,0;4:0,0,0,0
exists,	4:0,0,0,0
many	4:0,0,0,0;4:0,0,0,0
mammals	4:0,0,0,0
entire	4:0,0,0,0
mass	4:0,0,0,0
trans	4:0,0,0,0
reactions	4:0,0,0,0
enzymatic	4:0,0,0,0
changes	4:0,0,0,0
decidedly	4:0,0,0,0
firmer	4:0,0,0,0;4:0,0,0,0
involved.	4:0,0,0,0
sets	4:0,0,0,0
spontaneously,	4:0,0,0,0
resistance	4:0,0,0,0
obvious	4:0,0,0,0
physical	4:0,0,0,0
alteration	4:0,0,0,0
takes	4:0,0,0,0
offers	4:0,0,0,0
stream	4:0,0,0,0
hastens	4:0,0,0,0
place	4:0,0,0,0
production	4:0,0,0,0
sub	4:0,0,0,0
haemostasis.	4:0,0,0,0
relative	4:0,0,0,0
ease	4:0,0,0,0
preparation	4:0,0,0,0;4:0,0,0,0
stance	4:0,0,0,0
moment	4:0,0,0,0
previously	4:0,0,0,0
existed	4:0,0,0,0
renders	4:0,0,0,0
particularly	4:0,0,0,0
soluble,	4:0,0,0,0
fluid,	4:0,0,0,0
state.	4:0,0,0,0
essential	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0
aid	4:0,0,0,0
military	4:0,0,0,0
emergency	4:0,0,0,0
fibrinous	4:0,0,0,0;4:0,0,0,0
structure-	4:0,0,0,0
suigery.”	4:0,0,0,0
semi-solid	4:0,0,0,0
character.	4:0,0,0,0
investigations	4:0,0,0,0
f.	4:0,0,0,0;4:0,0,0,0
lfred	4:0,0,0,0;4:0,0,0,0
ess	4:0,0,0,0;4:0,0,0,0
delicate	4:0,0,0,0
network	4:0,0,0,0
forms	4:0,0,0,0
laboratories	4:0,0,0,0
new	4:0,0,0,0;4:0,0,0,0
york	4:0,0,0,0;4:0,0,0,0
city	4:0,0,0,0;4:0,0,0,0
agent	4:0,0,0,0
eventually	4:0,0,0,0
stops	4:0,0,0,0
health	4:0,0,0,0
confirmed	4:0,0,0,0
findings	4:0,0,0,0
closing	4:0,0,0,0
openings	4:0,0,0,0
wounded	4:0,0,0,0;5:0,0,0,0
blood-vessels.	4:0,0,0,0
howell	4:0,0,0,0
hirschfelder,	4:0,0,0,0
whereby	4:0,0,0,0
kephalin-like	4:0,0,0,0
element	4:0,0,0,0;4:0,0,0,0
coagu	4:0,0,0,0
agents.	4:0,0,0,0;4:0,0,0,0
lation	4:0,0,0,0
calcium	4:0,0,0,0;4:0,0,0,0
salts	4:0,0,0,0;4:0,0,0,0
process.	4:0,0,0,0
hess	4:0,0,0,0
described	4:0,0,0,0;5:0,0,0,0
delayed	4:0,0,0,0;4:0,0,0,0
specimen	4:0,0,0,0
human	4:0,0,0,0
ox	4:0,0,0,0
brain,	4:0,0,0,0
designated	4:0,0,0,0
thrombo	4:0,0,0,0
plastin.	4:0,0,0,0
demonstrated	4:0,0,0,0
efficacy	4:0,0,0,0
result	4:0,0,0,0
deficiency	4:0,0,0,0
true	4:0,0,0,0
hemophilia,	4:0,0,0,0
suggested	4:0,0,0,0;5:0,0,0,0
formation.	4:0,0,0,0
dental	4:0,0,0,0
surgery,	4:0,0,0,0
gastric	4:0,0,0,0;5:0,0,0,0
hemorrhage.	4:0,0,0,0;5:0,0,0,0
dependent	4:0,0,0,0
upon	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
missing	4:0,0,0,0
auspices	4:0,0,0,0
depart	4:0,0,0,0
cycle	4:0,0,0,0
formation	4:0,0,0,0
precursors;	4:0,0,0,0
ment	4:0,0,0,0
health,	4:0,0,0,0
ohn	4:0,0,0,0
ronin	4:0,0,0,0
fibrinogen,	4:0,0,0,0
thrombin,	4:0,0,0,0
salts,	4:0,0,0,0
routine	4:0,0,0,0;4:0,0,0,0
application	4:0,0,0,0
thromboplastin	4:0,0,0,0;4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0;5:0,0,0,0
(hess)	4:0,0,0,0
following	4:0,0,0,0;5:0,0,0,0
surgery	4:0,0,0,0
2,036	4:0,0,0,0
throat	4:0,0,0,0
operations.	4:0,0,0,0
says:	4:0,0,0,0
much	4:0,0,0,0
past	4:0,0,0,0
based	4:0,0,0,0
hypothesis	4:0,0,0,0
deficient	4:0,0,0,0;4:0,0,0,0
elements	4:0,0,0,0
add,	4:0,0,0,0
conclusion,	4:0,0,0,0
single	4:0,0,0,0
instance	4:0,0,0,0
operator	4:0,0,0,0
nurse	4:0,0,0,0
compelled	4:0,0,0,0
clotting	4:0,0,0,0
time	4:0,0,0,0
return	4:0,0,0,0
clinic	4:0,0,0,0
care	4:0,0,0,0
bleeder	4:0,0,0,0
reinforced	4:0,0,0,0
augmented	4:0,0,0,0
addition	4:0,0,0,0;5:0,0,0,0
tion	4:0,0,0,0
since	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
serum	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
products	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0
procedure.	4:0,0,0,0
developed	4:0,0,0,0
horse	4:0,0,0,0;4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
“thromboplastin	4:0,0,0,0
safe,	4:0,0,0,0
effective	4:0,0,0,0
easily	4:0,0,0,0
applied.”	4:0,0,0,0
serum,	4:0,0,0,0;4:0,0,0,0
platelets	4:0,0,0,0
administration	4:0,0,0,0;5:0,0,0,0
accordance	4:0,0,0,0
direction	4:0,0,0,0
con-	4:0,0,0,0
calcium.	4:0,0,0,0
recently	4:0,0,0,0
4,	4:0,0,0,0
tissue	4:0,0,0,0;5:0,0,0,0;5:0,0,0,0
come	4:0,0,0,0
prominence	4:0,0,0,0
american	4:0,0,0,0;4:0,0,0,0
association,	4:0,0,0,0;4:0,0,0,0
pril	4:0,0,0,0
24,	4:0,0,0,0
1915.	4:0,0,0,0
feb.	4:0,0,0,0
19,1916.	4:0,0,0,0
tains	5:0,0,0,0
substance	5:0,0,0,0
hirschfelder.	5:0,0,0,0
rendered	5:0,0,0,0
0.3	5:0,0,0,0
percent,	5:0,0,0,0
tricresol,	5:0,0,0,0
standardized	5:0,0,0,0
power.	5:0,0,0,0
composition	5:0,0,0,0
activity,	5:0,0,0,0
ready	5:0,0,0,0;5:0,0,0,0
immediate	5:0,0,0,0;5:0,0,0,0
use.	5:0,0,0,0
isotonic	5:0,0,0,0
fluids	5:0,0,0,0
freely	5:0,0,0,0
surfaces	5:0,0,0,0
without	5:0,0,0,0
irri	5:0,0,0,0
tation	5:0,0,0,0
injury.	5:0,0,0,0
types	5:0,0,0,0;5:0,0,0,0
hem	5:0,0,0,0
orrhage	5:0,0,0,0
small	5:0,0,0,0;5:0,0,0,0
veins	5:0,0,0,0
capillaries.	5:0,0,0,0
applied	5:0,0,0,0
locally	5:0,0,0,0
region	5:0,0,0,0
rectum	5:0,0,0,0
fol	5:0,0,0,0
lowing	5:0,0,0,0
operations	5:0,0,0,0
otherwise.	5:0,0,0,0
administered	5:0,0,0,0;5:0,0,0,0
mouth	5:0,0,0,0
ulcer,	5:0,0,0,0
20	5:0,0,0,0
(20	5:0,0,0,0
cc.)	5:0,0,0,0
diluted	5:0,0,0,0
twelve	5:0,0,0,0
fifteen	5:0,0,0,0
advantages	5:0,0,0,0
squibb,	5:0,0,0,0;5:0,0,0,0
extensively	5:0,0,0,0
used,	5:0,0,0,0
always	5:0,0,0,0
hesitation	5:0,0,0,0
account	5:0,0,0,0
anaphylaxis.	5:0,0,0,0
proteins	5:0,0,0,0
frequently	5:0,0,0,0
conveying	5:0,0,0,0
immunity	5:0,0,0,0
diseases,	5:0,0,0,0
antitoxins	5:0,0,0,0
antisera,	5:0,0,0,0
individual	5:0,0,0,0
sensitized	5:0,0,0,0
en	5:0,0,0,0
countered	5:0,0,0,0
time.	5:0,0,0,0
ox,	5:0,0,0,0
previous	5:0,0,0,0
sensitization	5:0,0,0,0
ox-proteins	5:0,0,0,0
rarely	5:0,0,0,0
encountered.	5:0,0,0,0
contains	5:0,0,0,0
amount	5:0,0,0,0
matter	5:0,0,0,0
proportion	5:0,0,0,0
present	5:0,0,0,0
urticaria	5:0,0,0,0
rash,	5:0,0,0,0
often	5:0,0,0,0
protein,	5:0,0,0,0
usually	5:0,0,0,0
thereby	5:0,0,0,0
avoided.	5:0,0,0,0
prophylactic	5:0,0,0,0
treatment,	5:0,0,0,0
operative	5:0,0,0,0
cedures,	5:0,0,0,0
increasing	5:0,0,0,0
blood,	5:0,0,0,0
concealed	5:0,0,0,0
hemorrhage,	5:0,0,0,0
special	5:0,0,0,0
product.	5:0,0,0,0
hypodermic	5:0,0,0,0
elab	5:0,0,0,0
orated.	5:0,0,0,0
permanent	5:0,0,0,0
solution,	5:0,0,0,0
subcutaneous	5:0,0,0,0
intramuscular	5:0,0,0,0
adminis	5:0,0,0,0
tration.	5:0,0,0,0